24595198|t|Brain pyroglutamate amyloid-beta is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer's disease therapeutic.
24595198|a|Pyroglutamate amyloid-beta peptides (pGlu-Abeta) are particularly pernicious forms of amyloid-beta peptides (Abeta) present in Alzheimer's disease (AD) brains. pGlu-Abeta peptides are N-terminally truncated forms of full-length Abeta peptides (flAbeta(1-40/42)) in which the N-terminal glutamate is cyclized to pyroglutamate to generate pGlu-Abeta(3-40/42). beta-secretase cleavage of amyloid-beta precursor protein (AbetaPP) produces flAbeta(1-40/42), but it is not yet known whether the beta-secretase BACE1 or the alternative beta-secretase cathepsin B (CatB) participate in the production of pGlu-Abeta. Therefore, this study examined the effects of gene knockout of these proteases on brain pGlu-Abeta levels in transgenic AbetaPPLon mice, which express AbetaPP isoform 695 and have the wild-type (wt) beta-secretase activity found in most AD patients. Knockout or overexpression of the CatB gene reduced or increased, respectively, pGlu-Abeta(3-40/42), flAbeta(1-40/42), and pGlu-Abeta plaque load, but knockout of the BACE1 gene had no effect on those parameters in the transgenic mice. Treatment of AbetaPPLon mice with E64d, a cysteine protease inhibitor of CatB, also reduced brain pGlu-Abeta(3-42), flAbeta(1-40/42), and pGlu-Abeta plaque load. Treatment of neuronal-like chromaffin cells with CA074Me, an inhibitor of CatB, resulted in reduced levels of pGlu-Abeta(3-40) released from the activity-dependent, regulated secretory pathway. Moreover, CatB knockout and E64d treatment has been previously shown to improve memory deficits in the AbetaPPLon mice. These data illustrate the role of CatB in producing pGlu-Abeta and flAbeta that participate as key factors in the development of AD. The advantages of CatB inhibitors, especially E64d and its derivatives, as alternatives to BACE1 inhibitors in treating AD patients are discussed.
24595198	0	19	Brain pyroglutamate	Chemical	-
24595198	20	32	amyloid-beta	Gene	351
24595198	48	59	cathepsin B	Gene	13030
24595198	110	114	E64d	Chemical	MESH:C108192
24595198	141	160	Alzheimer's disease	Disease	MESH:D000544
24595198	174	187	Pyroglutamate	Chemical	MESH:D011761
24595198	211	215	pGlu	Chemical	-
24595198	216	221	Abeta	Gene	351
24595198	283	288	Abeta	Gene	351
24595198	301	320	Alzheimer's disease	Disease	MESH:D000544
24595198	322	324	AD	Disease	MESH:D000544
24595198	334	338	pGlu	Chemical	-
24595198	339	344	Abeta	Gene	351
24595198	402	407	Abeta	Gene	351
24595198	460	469	glutamate	Chemical	MESH:D018698
24595198	485	498	pyroglutamate	Chemical	MESH:D011761
24595198	511	515	pGlu	Chemical	-
24595198	559	589	amyloid-beta precursor protein	Gene	351
24595198	591	598	AbetaPP	Gene	351
24595198	678	683	BACE1	Gene	23821
24595198	718	729	cathepsin B	Gene	13030
24595198	731	735	CatB	Gene	13030
24595198	770	774	pGlu	Chemical	-
24595198	775	780	Abeta	Gene	11820
24595198	870	874	pGlu	Chemical	-
24595198	875	880	Abeta	Gene	11820
24595198	913	917	mice	Species	10090
24595198	933	940	AbetaPP	Gene	11820
24595198	1019	1021	AD	Disease	MESH:D000544
24595198	1022	1030	patients	Species	9606
24595198	1066	1070	CatB	Gene	13030
24595198	1112	1116	pGlu	Chemical	-
24595198	1155	1159	pGlu	Chemical	-
24595198	1160	1165	Abeta	Gene	11820
24595198	1199	1204	BACE1	Gene	23821
24595198	1262	1266	mice	Species	10090
24595198	1281	1291	AbetaPPLon	CellLine	
24595198	1292	1296	mice	Species	10090
24595198	1302	1306	E64d	Chemical	MESH:C108192
24595198	1341	1345	CatB	Gene	13030
24595198	1366	1370	pGlu	Chemical	-
24595198	1406	1410	pGlu	Chemical	-
24595198	1411	1416	Abeta	Gene	11820
24595198	1479	1486	CA074Me	Chemical	MESH:C400541
24595198	1504	1508	CatB	Gene	13030
24595198	1540	1544	pGlu	Chemical	-
24595198	1545	1556	Abeta(3-40)	Gene	11820
24595198	1634	1638	CatB	Gene	13030
24595198	1652	1656	E64d	Chemical	MESH:C108192
24595198	1704	1719	memory deficits	Disease	MESH:D008569
24595198	1738	1742	mice	Species	10090
24595198	1778	1782	CatB	Gene	13030
24595198	1796	1800	pGlu	Chemical	-
24595198	1801	1806	Abeta	Gene	11820
24595198	1873	1875	AD	Disease	MESH:D000544
24595198	1895	1899	CatB	Gene	13030
24595198	1923	1927	E64d	Chemical	MESH:C108192
24595198	1968	1973	BACE1	Gene	23821
24595198	1997	1999	AD	Disease	MESH:D000544
24595198	2000	2008	patients	Species	9606
24595198	Negative_Correlation	MESH:C400541	13030
24595198	Association	MESH:D008569	351
24595198	Negative_Correlation	MESH:C400541	11820
24595198	Association	MESH:D011761	MESH:D000544
24595198	Negative_Correlation	MESH:C108192	351
24595198	Negative_Correlation	MESH:C108192	MESH:D000544
24595198	Association	MESH:D000544	351
24595198	Positive_Correlation	MESH:C108192	MESH:D008569
24595198	Negative_Correlation	MESH:C108192	13030
24595198	Negative_Correlation	MESH:C108192	11820
24595198	Association	MESH:D008569	13030
24595198	Positive_Correlation	11820	13030

